Oral lipid nanoparticle drug can prevent development of colitis-associated cancer, researchers find
Date | 3rd, Oct 2023 |
---|---|
Source | Medical Xpress - Scientific News Websites |
DESCRIPTION
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.